UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of BIMZELX® (bimekizumab-bkzx)
Categories News Press Releases Archives 2026 September August July June May April March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May March February January 2023 December November October September August July June April January Apr 22 Earth Day 2025: Advancing Our Commitment to a Healthier Planet Read More
